These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 29196053)

  • 41. Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling.
    Khan S; Shukla S; Sinha S; Lakra AD; Bora HK; Meeran SM
    Int J Biochem Cell Biol; 2015 Jan; 58():1-16. PubMed ID: 25448414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF‑1α pathway.
    Kim A; Ma JY
    Int J Oncol; 2018 Sep; 53(3):1160-1170. PubMed ID: 30015877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apatinib Inhibits Angiogenesis in Intrahepatic Cholangiocarcinoma by Regulating the Vascular Endothelial Growth Factor Receptor-2/Signal Transducer and Activator of Transcription Factor 3/Hypoxia Inducible Factor 1 Subunit Alpha Signaling Axis.
    Huang MP; Gu SZ; Huang B; Li GW; Xiong ZP; Tang T; Zeng SN
    Pharmacology; 2021; 106(9-10):509-519. PubMed ID: 34412054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects and mechanisms of Xiao-Ai-Ping injection on angiogenesis].
    Wang MJ; Du DY; Fan W; Zhang C; Liu Y; Fan JH; Yuan ST; Lin SS
    Yao Xue Xue Bao; 2016 Feb; 51(2):309-15. PubMed ID: 29856586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
    Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway.
    Wang Z; Wang N; Han S; Wang D; Mo S; Yu L; Huang H; Tsui K; Shen J; Chen J
    PLoS One; 2013; 8(7):e68566. PubMed ID: 23861918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines.
    Jardim-Perassi BV; Lourenço MR; Doho GM; Grígolo IH; Gelaleti GB; Ferreira LC; Borin TF; Moschetta MG; Pires de Campos Zuccari DA
    Anticancer Agents Med Chem; 2016; 16(3):347-58. PubMed ID: 25963143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway.
    Saraswati S; Kumar S; Alhaider AA
    Mol Cancer; 2013 Nov; 12():147. PubMed ID: 24261856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SYP-5, a novel HIF-1 inhibitor, suppresses tumor cells invasion and angiogenesis.
    Wang LH; Jiang XR; Yang JY; Bao XF; Chen JL; Liu X; Chen GL; Wu CF
    Eur J Pharmacol; 2016 Nov; 791():560-568. PubMed ID: 27664769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells.
    Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC
    Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals.
    Zhao Y; You W; Zheng J; Chi Y; Tang W; Du R
    Clin Transl Oncol; 2016 Nov; 18(11):1123-1130. PubMed ID: 26942921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1alpha protein accumulation and vascular endothelial growth factor expression in human breast cancer cells.
    Tang XD; Zhou X; Zhou KY
    Acta Pharmacol Sin; 2009 May; 30(5):605-16. PubMed ID: 19349962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
    Su M; Huang J; Li J; Qin X; Tang X; Jin F; Chen S; Jiang C; Zou Z; Peng K; Nuruzzaman M; Zhang J; Luo J; Liu S; Luo Z
    Oncotarget; 2016 Apr; 7(14):19018-30. PubMed ID: 26967559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells.
    Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB
    Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of IQGAP1 promotes the angiogenesis of esophageal squamous cell carcinoma through the AKT and ERK‑mediated VEGF‑VEGFR2 signaling pathway.
    Li CH; Sun XJ; Niu SS; Yang CY; Hao YP; Kou JT; Li XZ; Wang XX
    Oncol Rep; 2018 Sep; 40(3):1795-1802. PubMed ID: 30015941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways.
    Park SH; Kim BR; Lee JH; Park ST; Lee SH; Dong SM; Rho SB
    Cell Signal; 2014 Jul; 26(7):1506-13. PubMed ID: 24686084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dietary isoflavone daidzein synergizes centchroman action via induction of apoptosis and inhibition of PI3K/Akt pathway in MCF-7/MDA MB-231 human breast cancer cells.
    Kaushik S; Shyam H; Sharma R; Balapure AK
    Phytomedicine; 2018 Feb; 40():116-124. PubMed ID: 29496164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NADPH oxidase subunit p22(phox)-mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer.
    Li Q; Fu GB; Zheng JT; He J; Niu XB; Chen QD; Yin Y; Qian X; Xu Q; Wang M; Sun AF; Shu Y; Rui H; Liu LZ; Jiang BH
    Biochim Biophys Acta; 2013 Dec; 1833(12):3375-3385. PubMed ID: 24113386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway.
    Tsai JL; Lee YM; Pan CY; Lee AY
    Curr Cancer Drug Targets; 2016; 16(3):275-86. PubMed ID: 26882030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.